FGFR4 is involved in cell proliferation and migration in melanoma. The anti-FGFR4 antibody conjugated liposome targets and inhibits these pathways, potentially reducing tumor growth. This targeted delivery system enhances the therapeutic efficacy of the treatment. Preclinical studies demonstrate promising results in shrinking melanoma tumors.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-065WM | Mouse Anti-FGFR4 Recombinant Antibody (TAB-065WM) | ELISA, FC | Mouse IgG |
TAB-067WM | Anti-Human FGFR4 Recombinant Antibody (F85-6C5) | IP, ELISA | |
TAB-068WM | Mouse Anti-FGFR4 Recombinant Antibody (TAB-068WM) | ELISA, WB | Mouse IgG |
TAB-069WM | Rat Anti-FGFR4 Recombinant Antibody (TAB-069WM) | ELISA, WB, FC, Inhib | Rat IgG |
TAB-065WM-F(E) | Mouse Anti-FGFR4 Recombinant Antibody; Fab Fragment (TAB-065WM-F(E)) | ELISA, FC | Mouse Fab |
There are currently no Customer reviews or questions for VS-1024-FY181. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.